4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-24-108373
SrVP/CFO/Prin Fin & Acct Ofcr bought 450 shares at $2.61 ($1,175)
From the SEC's structured data for this filing
Trades in this filing
Hamill John P. · SrVP/CFO/Prin Fin & Acct Ofcr
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-10 | Purchase : show line 1 in the form | +450 | $2.61 | $1,175 | 19,318 | D |
| Open-market purchases · 450 sh · avg $2.61 · $1,175 | ||||||
Loading xslF345X05/tm2426059-1_4seq1.xml…